In an effort to improve sustainability and reduce the cost of goods for active pharmaceutical ingredients (APIs), pharma companies have partnered on varying portions of their supply chain with contract providers. This approach brings with it numerous cost benefits but also logistical challenges. However, it also offers opportunities to integrate sustainable science via green chemistry and engineering more holistically into the entire sequence. The ACS Green Chemistry Institute Pharmaceutical Roundtable (GCIPR) provides a multicompany industrial view on how to address the challenges and best meet cost goals while enhancing the overall sustainability of the global pharmaceutical industry.
No takes yet. Share an insight, caveat, or question.
Koenig et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: